Journal
TRENDS IN IMMUNOLOGY
Volume 42, Issue 10, Pages 891-903Publisher
CELL PRESS
DOI: 10.1016/j.it.2021.08.005
Keywords
-
Categories
Funding
- National Institutes of Health [F30-AI140497, R01-AI088100, R01-NS120417]
- National Multiple Sclerosis Society [RG-1801-30040, PP-1509-06274]
Ask authors/readers for more resources
Dectin-1, a C-type lectin receptor expressed on myeloid cells, recognizes beta-glucans and induces antifungal proinflammatory immune responses. Apart from its known role in fungal infections, Dectin-1 has been found to promote tolerance, anti-inflammatory, and neuroprotective responses in certain contexts. Studies in neuroimmunology suggest potential new therapeutic approaches for modifying innate immune responses in neurological disorders.
Dectin-1 is a C-type lectin receptor (CLR) expressed on the surface of various mammalian myeloid cells. Dectin-1 recognizes beta-glucans and elicits antifungal proinflammatory immune responses. Recent studies have begun to examine the biology of Dectin-1 in previously less explored settings, such as homeostasis, sterile inflammation, and in the central nervous system. Indeed, in certain contexts, Dectin-1 is now known to promote tolerance, and anti-inflammatory and neuroprotective responses. In this review, we provide an overview of the current understanding of the roles of Dectin-1 in immunology beyond the context of fungal infections, mainly focusing on in vivo neuroimmunology studies, which could reveal new therapeutic approaches to modify innate immune responses in neurologic disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available